Product Description

ROWASA contains mesalamine (mesalazine) which belongs to the group of medicines called salicylates. It is an anti-inflammatory drug used to treat and prevent mild-to-moderate Ulcerative colitis. Ulcerative colitis is an inflammatory bowel disease in which the lining of the bowel, colon and rectum are inflamed and develops tiny breaks in its surface (ulcers) which may bleed.

ROWASA act locally in the colon and rectum and reduce inflammation. It can also prevent further episodes (flares) of ulcerative colitis. Along with this treatment, your doctor might recommend you, to avoid smoking and alcohol consumption, stick to simple meals and to drink plenty of water. Prior to the treatment, your doctor might take blood and urine test to access the function of your kidneys.

Open the foil sachet and empty the contents onto the tongue. Wash the granules down the throat immediately with some water or orange juice, ensuring that none remain in the mouth. Do not crush or chew the granules. Avoid concomitant use of ROWASA with other anti-inflammatory disease because it can increase the risk of side effects. On the course of treatment, regular monitoring of your liver, kidney and blood is required, to avoid any unwanted or toxic effects. If you are pregnant or think you may be pregnant, or breastfeeding inform your doctor before taking this medicine. The most common side effect of taking this medicine is abdominal pain, nausea, vomiting, bloating and headache.